Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 10/18/2024
Closing price: 321.66
| Support price level: | $312.08 |
| Resistance price level: | $337.75 |
| Relative strength index (14-day RSI) | 49.1 |
| Beta | 0.44 |
- AMGN is one of this month's worst performers with a return of -4.7%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- AMGN is above its 200-day moving average, providing a measure of support for long positions.
| Low | High | Price as % of Range |
| $255.70 | $337.38 | 82.8% |
| 200 day | 50 day | 20 day | 10 day |
| $305.96 | $325.84 | $322.09 | $322.12 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 25.5% | 20.1% | 21.4% | 24.2% |
- 5.8% in the next week.
- 13.7% in the next month.
- 47.3% in the next year.
